Evidence Check review brokered by the Sax Institute for the Mental Health Commission of nsw april 2013 This report was prepared by



Download 460.65 Kb.
Page1/17
Date25.04.2016
Size460.65 Kb.
#18238
  1   2   3   4   5   6   7   8   9   ...   17


The evidence on the costs and impacts on the economy and productivity due to mental ill health: a rapid review


Christopher M Doran

­­
An Evidence Check review brokered by the Sax Institute


for the Mental Health Commission of NSW
April 2013













This report was prepared by:

Christopher M Doran

Hunter Medical Research Institute, University of Newcastle, Australia.
April 2013
© Sax Institute 2013
This work is copyright. No part may be reproduced by any process except in accordance with the provisions

of the Copyright Act 1968.



Enquiries regarding this report may be directed to:

Knowledge Exchange Program

Sax Institute

Level 2, 10 Quay Street Haymarket NSW 2000

PO Box K617 Haymarket NSW 1240 Australia

T: +61 2 95145950

F: +61 2 95145951

Email: knowledge.exchange@saxinstitute.org.au



Suggested Citation:

Doran CM. The evidence on the costs and impacts on the economy and productivity due to mental ill health: an Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the Mental Health Commission of NSW, 2013.



Disclaimer:

This Evidence Check review was produced using the Evidence Check methodology in response to specific questions from the commissioning agency. It is not necessarily a comprehensive review of all literature relating to the topic area. It was current at the time of production (but not necessarily at the time of publication). It is reproduced for general information and third parties rely upon it at their own risk.


Contents


Contents 3

Abbreviations and terms used in this report 5

EXECUTIVE SUMMARY 7

1 Background 9

2 Introduction 10

3 Method used in current rapid review 11

Information sources 11

Search strategy 11

Results 11



4 Review question 1: What is the evidence on the costs and impacts on the economy and productivity due to mental illness? 13

The timeframe of estimated costs and impacts should be included; short, medium and long-term timeframes are all of interest 13

Key assumptions of the economic modelling approaches used should be included 14

Include expert opinion of the quality of the evidence 15

Where available, include evidence on the costs and impacts relative to those of other common health conditions (for example, cancer, diabetes, cardiovascular disease) 16

Include expert opinion on the potential gains to the economy and productivity from optimising the prevention and treatment of mental ill health across the population 19



5 Review question 2: What evidence gaps have been identified that would benefit from additional research particularly relevant to the NSW context? 21

Include gaps/key unanswered questions based on the findings from Review question1 21

Include expert opinion regarding other gaps/unanswered questions that are relevant to the NSW context and what could be done to address these gaps/unanswered questions 23

6 Tabulation of relevant studies 24

7 Conclusions 24

8 References 27

Appendix 1: Text summary of studies included in this rapid review 28

ADHD – UK study 28

Anxiety – Australian study 28

Cognitive function – UK study 28

Conduct disorder – UK study 29

Depression – Australian studies 29

Depression – Canadian studies 30

Depression – UK studies 30

Eating disorder – Australian study 31

Eating disorder – UK study 31

Mental disorder – Australian studies 32

Mental disorder – Canadian studies 33

Mental disorder – NZ study 35

Mental disorder – UK studies 35

Psychological distress – Australian studies 36

Schizophrenia – Australian studies 36

Schizophrenia – Canadian study 37

Schizophrenia – UK study 38



Appendix 2: Tabular summary of studies included in this rapid review 39


Abbreviations and terms used in this report


ABS

Australian Bureau of Statistics

ACE-MH

Assessing cost-effectiveness of Mental Health

ACE-Prevention

Assessing cost-effectiveness of Prevention

ACT

Assertive community treatment

ADHD

Attention deficit hyperactivity disorder

AIHW

Australian Institute of Health and Welfare

ALOS

Average length of stay

BFM

Behavioural family management

BIM

Behavioural intervention for families

BOD

Burden of disease

CBT

Cognitive behaviour therapy

CCBT

Computerised cognitive behaviour therapy

CD

Conduct disorder

CEA

Cost-effectiveness analysis

CMHP

Collaborative mental health care program

COI

Cost of illness

DALY

Disability-adjusted life year

DEX

Dexamphetamine

GAD

Generalised anxiety disorder

GP

General practitioner

HASI

Housing and Accommodation Support Initiative

HILDA

Household, Income and Labour Dynamics in Australia

HTA

Health Technology Assessment

HCA

Human capital approach

HRQOL

Health related quality of life

IPS

Individual placement and support

LOS

Length of stay

LPDS

Low Prevalence Disorders Study

MATISSE

Multicentre evaluation of art therapy In schizophrenia: systematic evaluation

MDD

Major depressive disorder

MDU

Mood disorder unit

MPH

Methylphenidate

MFG

Multiple family groups

NHS

National Health Service

NICE

National Institute Clinical Excellence

NPHS

National population health survey

NSMHWB

National Survey of Mental Health and Wellbeing

OHP

Optimal health program

PD

Psychiatric diagnoses

PEP

Primary care evidence-based psychological interventions

PRIZE

Partial responders international schizophrenia evaluation

QALY

Quality-adjusted life year

QOL

Quality of life

REACT

Randomised evaluation of assertive community treatment

SCAP

Schizophrenia care and assessment programme

SE

Supported employment

SGA

Second-generation antipsychotics

SNRIs

Serotonin and noradrenaline reuptake inhibitor

SWAN

Supported work and needs trial


Download 460.65 Kb.

Share with your friends:
  1   2   3   4   5   6   7   8   9   ...   17




The database is protected by copyright ©essaydocs.org 2023
send message

    Main page